Open access · CC-BY
via OpenAlex
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
Daniel C. Zank, Marta Bueno, Ana Lucia Mora, Mauricio M. Rojas
Frontiers in Medicine · 2018 · ▲ 155 citations
Abstract
At present, the etiology of idiopathic pulmonary fibrosis (IPF) remains elusive. Over the past two decades, however, researchers have identified and described the underlying processes that result in metabolic dysregulation, metabolic reprogramming, and mitochondrial dysfunction(definition) observed in the cells of IPF lungs. Metabolic changes and mitochondrial dysfunction in IPF include decreased efficiency of electron transport chain function with increasing production of reactive oxygen species, decreased mitochondrial biogenesis, and impaired mitochondrial macroautophagy, a key pathway for the removal of dysfunctional mitochondria. Metabolic changes in IPF have potential impact on lung cell function, differentiation, and activation of fibrotic responses. These alterations result in activation of TGF-β and predispose to the development of pulmonary fibrosis. IPF is a disease of the aged, and many of these same bioenergetic changes are present to a lesser extent with normal aging, raising the possibility that these anticipated alterations in metabolic processes play important roles in creating susceptibility to the development of IPF. This review explores what is known regarding the cellular metabolic and mitochondrial changes that are found in IPF, and examines this body of literature to identify future research direction and potential points of intervention in the pathogenesis of IPF.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fmed.2018.00010
- Canonical
- link ↗
- Fetched
- 2026-09-26 MST
Cite this
APA
Zank, D.C., Bueno, M., Mora, A.L., & Rojas, M.M. (2018). Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics. <em>Frontiers in Medicine</em>. https://doi.org/10.3389/fmed.2018.00010
Vancouver
Zank DC, Bueno M, Mora AL, Rojas MM. Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics. Frontiers in Medicine. 2018. doi:10.3389/fmed.2018.00010.
BibTeX
@article{daniel2018Idiopa,
title = {Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics},
author = {Daniel C. Zank and Marta Bueno and Ana Lucia Mora and Mauricio M. Rojas},
journal = {Frontiers in Medicine},
year = {2018},
doi = {10.3389/fmed.2018.00010},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Redox Biology 2020
Open access · CC-BY
Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis
Molecular Neurodegeneration 2023
Open access · CC-BY
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Journal of Clinical Investigation 2017
Open access · OA
Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis
Revista de investigaci�n Cl�nica 2016
Open access · CC-BY
Aging and Pulmonary Fibrosis
Annals of the American Thoracic Society 2016
Citation only
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis
International Journal of Molecular Sciences 2009
Open access · CC-BY